findmyKOL
Clinical trialNCT02465437TerminatedPhase 2Interventional

Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis

SponsorCorbus Pharmaceuticals Inc.Enrollment42Diffuse Cutaneous Systemic Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Robert Spiera, M.D.

    Weill Cornell Medical College, New York City, NY

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arthritis Association of Southern Ca

    Los Angeles, California, United States

  • Stanford University

    Palo Alto, California, United States

  • John Hopkins Scleroderma Center

    Baltimore, Maryland, United States

  • Boston University Medical Center

    Boston, Massachusetts, United States

  • Rutgers University

    New Brunswick, New Jersey, United States

  • Weill Cornell Medical College

    New York, New York, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

  • University of Texas Houston Medical School

    Houston, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2015
Primary completion
31 Oct 2016
Completion
11 Dec 2020
Last update posted
21 Apr 2021
Registered enrollment
42
Registry id
NCT02465437

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.